CURE CANCER FASTER
Jogzz will donate 5% of all sales to the Fred Hutch
Cancer Research Center

Jogzz will donate 5% of all sales to Fred Hutchinson Cancer Research Center to help fuel their efforts to eliminate cancer. This donation will be fully transparent and reported quarterly on the Jogzz website. We are proud to have donated $4,800 in 2018.

Here is a paragraph from the Hutch thanking us for our first donation.  As we read this we fully understand how important our giving is.

Your support makes possible scientific discoveries that are transforming lives and bringing cures closer for more and more patients.  Built upon four decades of innovation, our instigative culture thrives on creative thinking and collaboration.  Gifts like your fuel that innovation, enabling our scientist to explore bold ideas that have revolutionized cancer research and are yielding new therapies, effective prevention strategies and powerful diagnostics.

Thank you again for your ongoing in investment in lifesaving cancer research.

Cancer does not discriminate. Based on our family experience, we believe this terrible disease touches virtually every family. If it is not you, it is an immediate family member, or a close friend. It generates fear, complex treatments, and too often loss of life. This drives our commitment to partner with Fred Hutch to cure cancer faster.

We seek to create a virtuous circle for our business – the more we sell, the more we give. We hope our customers will not only love our joggers with a zipper fly, but will also help promote our work to fund cancer research by reviewing our products and referring them to friends and family

Jogzz will donate 5% of all sales to Fred Hutchinson Cancer Research Center to help fuel their efforts to eliminate cancer. This donation will be fully transparent and reported quarterly on the Jogzz website. We are proud to have donated $4,800 in 2018.

We thank all those that have reviewed our products.  Reviews drive sales, and sales drives donations.

Here is a paragraph from the Hutch thanking us for our first donation.  As we read this we fully understand how important our giving is.

Your support makes possible scientific discoveries that are transforming lives and bringing cures closer for more and more patients.  Built upon four decades of innovation, our instigative culture thrives on creative thinking and collaboration.  Gifts like your fuel that innovation, enabling our scientist to explore bold ideas that have revolutionized cancer research and are yielding new therapies, effective prevention strategies and powerful diagnostics.

Thank you again for your ongoing in investment in lifesaving cancer research.

Cancer does not discriminate. Based on our family experience, we believe this terrible disease touches virtually every family. If it is not you, it is an immediate family member, or a close friend. It generates fear, complex treatments, and too often loss of life. This drives our commitment to partner with Fred Hutch to cure cancer faster.

We seek to create a virtuous circle for our business – the more we sell, the more we give. We hope our customers will not only love our joggers with a zipper fly, but will also help promote our work to fund cancer research by reviewing our products and referring them to friends and family

Jogzz founder, Victor Alhadeff, has a personal story closely intertwined with Fred Hutch and advancements in cancer treatments. He was diagnosed with prostate cancer in 1997 and had a radical prostatectomy, a major surgery at the time. Since then, medical advancements made it a much simpler procedure. Ten years later, he was diagnosed with multiple myeloma, which at the time had a life expectancy of less than two years. He underwent a stem cell transplant and extensive chemotherapy treatment. Only because of advancements in treatment, Victor is now able to start this new business and enjoy life with his wife of almost 50 years, Susan, his three married children, and thirteen wonderful grandchildren.

Victor and his family have supported Fred Hutch for more than 20 years. In 2017, Victor took his commitment to Cure Cancer Faster to the road and biked 25 miles for Fred Hutch Obliteride, something that would not be possible without medical advancements discovered by Fred Hutch.

Jogzz founder, Victor Alhadeff, has a personal story closely intertwined with Fred Hutch and advancements in cancer treatments. He was diagnosed with prostate cancer in 1997 and had a radical prostatectomy, a major surgery at the time. Since then, medical advancements made it a much simpler procedure. Ten years later, he was diagnosed with multiple myeloma, which at the time had a life expectancy of less than two years. He underwent a stem cell transplant and extensive chemotherapy treatment. Only because of advancements in treatment, Victor is now able to start this new business and enjoy life with his wife of almost 50 years, Susan, his three married children, and thirteen wonderful grandchildren.

Victor and his family have supported Fred Hutch for more than 20 years. In 2017, Victor took his commitment to Cure Cancer Faster to the road and biked 25 miles for Fred Hutch Obliteride, something that would not be possible without medical advancements discovered by Fred Hutch.

ABOUT FRED HUTCHINSON CANCER RESEARCH CENTER

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.

WHY SUPPORT FRED HUTCH?

GLOBAL LEADER: Fred Hutch aims to eliminate cancer and related diseases as causes of human suffering and death. Home to three Nobel laureates and interdisciplinary teams of world-renowned scientists, Fred Hutch is a global leader in research to prevent, detect and treat cancer and other life-threatening diseases.

BONE MARROW TRANSPLANTATION PIONEER: Fred Hutch scientists pioneered bone marrow transplantation—considered the #1 therapy for treating leukemia, lymphoma and multiple myeloma. It has also been used to cure AIDS and is being tested for application with other diseases. More than one million bone marrow transplants have been performed all over the world, extending and saving hundreds of thousands of lives.

DISCOVERING BETTER TREATMENTS: The Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. Today, immunotherapy is one of the most promising frontiers for less toxic, more effective cancer treatments. Fred Hutch continues to lead this field by creating therapies that retarget immune cells to fight cancer more effectively.

DISEASE PREVENTION: Fred Hutch houses the nation’s first and largest cancer prevention research program. We also have an entire division of world-leading researchers devoted to understanding and preventing infectious diseases. This research synergy is critical for discovery, and it gives us a unique ability to combat the roughly 25 percent of cancers worldwide that are caused by infectious disease.

INTERDISCIPLINARY INSIGHTS: From basic biology to programs that enhance the quality of life for survivors, our world-renowned scientists take an innovative and comprehensive research approach to understanding and eliminating more than two dozen types of cancer and other life-threatening illnesses. Collaboration across research labs and scientists also helps reveal commonalities between different types of cancers—as well as how drugs developed for one type might also prove highly effective for another.

SCIENTIFIC EXCELLENCE: Our long history of scientific excellence and research breakthroughs gives Fred Hutch scientists a competitive edge when applying for grants. As a result, they consistently garner more annual funding from the National Cancer Institute than any other research institute.

POWERFUL PARTNERSHIPS: As an academic, teaching, and research institution, Fred Hutch works collaboratively with researchers in more than 60 countries to develop lifesaving, leading-edge therapies.

TOGETHER WE CAN END CANCER: Fred Hutch scientists hold some of the greatest promise in understanding, curing and preventing cancer. Contributions from supporters fund critical areas of need that may otherwise go unsupported and accelerate research to save lives faster.

FRED HUTCH BY THE NUMBERS

  • 3 Nobel Laureates
  • 5 research divisions to decode cancer and other diseases, from cause to cure
  • 15 acre campus in Seattle’s South Lake Union “Innovation District”
  • 30 biotech companies launched as a result of Fred Hutch innovations
  • 250+ clinical trials available in cooperation with research partners
  • 300+ labs and projects from basic biology to developing next generation of treatments
  • 500+ secondary school teachers have received mentorship and resources at the Hutch to enhance their teaching
  • 2800+ highly skilled scientists and staff
  • 100,000+ secondary school students who have benefited from Fred Hutch education programs
  • 1 million people worldwide have participated in Fred Hutch public health studies
  • 1.3 million square feet of cutting-edge laboratories and offices

FROM FRED HUTCH PRESIDENT

“We’ve made enormous progress in treating cancer patients and improving their quality of life, but our goal is to cure cancer. For the first time, for me at least, I can see it coming across a broad spectrum of human cancers. The place where that will happen — the leading edge for that — is Fred Hutch.”

Gary Gilliland, M.D., Ph.D., President and Director

Dr. Gary Gilliland, a renowned physician-scientist, took the helm as Fred Hutch’s president and director on Jan. 2, 2015. Gilliland is an expert in cancer genetics and precision medicine who has devoted his life to finding better treatments and cures for diseases. Gilliland, who holds a Ph.D. in microbiology as well as a medical doctorate, spent 20 years on the faculty at Harvard where he was professor of medicine at Harvard Medical School and professor of stem cell and regenerative biology at Harvard University. He was also an investigator at the Howard Hughes Medical Institute and the director of the leukemia program at the Dana-Farber/Harvard Cancer Center. He has earned numerous honors for his work, including election to the National Academy of Medicine in 2015.

WHO WAS FRED HUTCHINSON?

Fred Hutchinson ranks as arguably the biggest Seattle sports hero of them all — a top-flight major-league pitcher and manager whose career was cut short by cancer. In the golden era of Pacific Coast League baseball, Fred’s performance for the Seattle Rainiers in 1938 reached a stature that will likely have no equal. He amassed a sterling 25-7 record, winning his 19th game on his 19th birthday in front of a record crowd of 16,354 that lined the outfield fences three rows deep at Seattle’s historic Sick Stadium. Fred then reached national fame with the Detroit Tigers, winning 95 games over 11 years and notching 18- and 17-win seasons in 1947 and 1950. He later managed the Seattle Rainiers, Tigers, St. Louis Cardinals, and Cincinnati Reds, which he piloted to the World Series in 1961.

Tragically, the man known for his tenacity, winning determination and courage died of lung cancer in 1964 at the age of 45. With that legacy, Fred’s brother, Dr. Bill Hutchinson, a Seattle surgeon and an athlete in his own youthful heyday, sought to establish a living memorial to Fred: Fred Hutchinson Cancer Research Center. Today, Fred Hutch is a world leader in research on the prevention, diagnosis and treatment of cancer, HIV/AIDS and other life-threatening diseases.